ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrea M. D'Armini
Thomas M. Egan
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Armini, A. M.
Right arrow Articles by Egan, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Armini, A. M.
Right arrow Articles by Egan, T. M.

Ann Thorac Surg 1996;62:1448-1453
© 1996 The Society of Thoracic Surgeons


Original Article: General Thoracic

Studies of Rat Lung Viability and Adenine Nucleotide Metabolism After Death

Andrea M. D'Armini, MD, John J. Lemasters, MD, PhD, Thomas M. Egan, MD

Division of Cardiothoracic Surgery, Department of Surgery, and Department of Cell Biology and Anatomy, University of North Carolina School of Medicine, Chapel Hill, North Carolina, and Division of Cardiac Surgery, University of Pavia, and IRCCS Policlinico San Matteo, Pavia, Italy


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Background. Prior studies from our laboratory have supported the use of cadaveric lungs for transplantation. In this study we investigated different preservation strategies for lungs retrieved from cadavers 4 hours after circulatory arrest.

Methods. Seventy-two Sprague-Dawley rats were sacrificed and then ventilated with 100% oxygen for 4 hours. The lungs were then flushed with modified Euro-Collins, University of Wisconsin, or Carolina rinse solution, either alone, with prostaglandin E1, or with prostaglandin E1 plus the free radical scavenger dimethylthiourea. After an additional 4-hour cold storage, the left lung was flushed with trypan blue solution to quantify cell viability, whereas the right lung was used to determine wet-to-dry weight ratios and to measure the levels of the adenine nucleotides adenosine triphosphate, adenosine diphosphate, and adenosine monophosphate by high-performance liquid chromatography.

Results. Viability was consistently better in the lungs flushed with Carolina rinse solution; these differences were statistically significant compared with those in the corresponding modified Euro-Collins subgroups (p < 0.005). The addition of prostaglandin E1 to all three preservation solutions improved the total adenine nucleotide levels; this increase was statistically significant for the modified Euro-Collins subgroup (p < 0.005). The total adenine nucleotide levels for the University of Wisconsin subgroups were higher than those for the corresponding modified Euro-Collins subgroups. The highest total adenine nucleotide levels were obtained in lungs flushed with Carolina rinse plus prostaglandin E1. Wet-to-dry weight ratios were always significantly lower in the lungs preserved with University of Wisconsin solution (p < 0.05), with a value similar to that of fresh tissue.

Conclusions. The characteristics of the solution used to flush and to store rat cadaveric lungs have an impact on lung viability and adenine nucleotide metabolism. The ideal preservation strategy may allow for lung retrieval from cadavers for safe transplantation.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
The paucity of viable lung donors is currently a severe limitation in lung transplantation. If it were possible to retrieve lungs from non–heart beating cadaver donors for transplantation, the size of the lung donor pool would increase considerably.

In our laboratory, we have demonstrated the feasibility of lung transplantation using cadaver donors in dogs [1, 2]. Subsequently we performed experiments using a rat model to determine the time course of pulmonary cell death after circulatory arrest [3]. Oxygen ventilation of cadaver lungs was found to delay significant cell death and ultrastructural damage [4] and to maintain adenine nucleotide levels in nonperfused lungs [5]. Recently we evaluated the impact of hypothermic storage on rat lungs retrieved 4 hours after death and flushed with either modified Euro-Collins or University of Wisconsin solution [6]. Because we had previously shown a beneficial effect from the use of the free radical scavenger dimethylthiourea (DMTU) in canine lung preservation [7, 8], we chose to study the effects of the addition of this agent and prostaglandin E1 (PGE1) to perfusate solutions of rat lungs retrieved from cadavers.

The current study was undertaken to evaluate three preservation solutions used alone, with PGE1, or with PGE1 and DMTU. A perfusate solution has been developed at this institution for use as a "rinse" of liver grafts after a period of ischemia [9, 10], and we elected to evaluate it as a preservation solution for lungs retrieved from cadavers.


    Material and Methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
The Institutional Animal Care and Use Committee of the University of North Carolina at Chapel Hill reviewed and approved the protocol for this study. All of the animals received humane care in accordance with the "Guide for the Care and Use of Laboratory Animals" (NIH publication 85-23, revised 1985).

Animal Preparation
Seventy-two Sprague-Dawley rats weighing 300 to 500 g were sacrificed with an intraperitoneal injection of 1 mL of pentobarbital (Anpro Pharmaceuticals, Arcadia, CA) and then ventilated with 100% oxygen for 4 hours.

Immediately after the sacrifice of each of the animals, a cervical tracheotomy was performed, an 8F cannula was inserted, and mechanical ventilation was established using a Harvard rodent ventilator (model 683; Harvard Apparatus Company, Inc, Millis, MA) that delivered 100% oxygen with a tidal volume of 0.01 mL/g at a rate of 30 breaths/min. After a median sternotomy was performed, 300 units of heparin (Elkins-Sinn, Cherry Hill, NJ) was injected into the pulmonary artery and delivered into the lungs by compression of the heart, then the chest was closed with skin staples (Davis and Geck, Danbury, CT).

Specimen Preparation and Experimental Groups
At 4 hours postmortem, the chest was reopened and the venae cavae (left superior, right superior, and right inferior) were ligated. A 20-gauge catheter was inserted into the main pulmonary artery, and a left atriotomy was made. The animals were divided into three primary study groups of 24 animals each: (1) modified Euro-Collins (EC) group, (2) University of Wisconsin (UW) group, and (3) Carolina rinse (CR) group. Through the catheter, each rat received a 50-mL infusion of EC (Fresenius USA, Inc, Benicia, CA), UW (DuPont Merck Pharmaceutical Co, Wilmington, DE), or CR (University of North Carolina, John Lemasters) solution over 5 to 10 minutes. For each flush solution, three interventions were investigated: plain solution (EC-1, UW-1, CR-1), plain solution with 250-µg/L PGE1 (Upjohn Co, Kalamazoo, MI) (EC-2, UW-2, CR-2), or plain solution with 250-µg/L PGE1 and 50-mmol/L DMTU (Aldrich Chemical Co, Milwaukee, WI) (EC-3, UW-3, CR-3) (Table 1Go). This produced nine subgroups with 8 animals in each subgroup.


View this table:
[in this window]
[in a new window]
 
Table 1. . Composition of Modified Euro-Collins, University of Wisconsin, and Carolina Rinse Solutions
 
The infusion reservoir was positioned 25 cm above the heart. Mechanical ventilation was maintained during infusion. When flushing was completed, the trachea was clamped with the lungs fully expanded. The heart-lung block was then removed and stored at 0° to 4°C in the flush solution appropriate to the group.

At the end of a 4-hour hypothermic storage period, the heart-lung block was removed from the solution. The right hilum was clamped, and the right lung was excised, cut into three parts, flash frozen in liquid nitrogen, and stored at -70°C until subsequent high-performance liquid chromotography (HPLC) analysis. A 20-gauge catheter was then reinserted into the main pulmonary artery. Trypan blue (Sigma Chemical Co, St. Louis, MO) was dissolved in Krebs-Ringers-HEPES buffer (pH, 7.4), and 50 mL of 500-µmol/L solution was infused over 10 minutes, followed by 50 mL of 2 + 2 fixative (2% glutaraldehyde + 2% paraformaldehyde in 0.1-mol/L Sorenson's buffer), infused over another 10 minutes. The infusion reservoirs were positioned 25 cm above the heart. During the two successive infusions, mechanical ventilation was reestablished briefly with the same parameters, except for the tidal volume, which was halved. The midportion of the left lung was then excised and stored at 4°C in the same fixative.

Histology and Viability Assessment
One histologic section of the midportion of the blue-stained left lung from each rat was prepared, using previously described standard techniques [3]. Briefly, the tissue was dehydrated in ethanol, washed in xylene, and embedded in paraffin. Sections 5 µm in thickness were cut on a microtome, mounted on glass slides, and counterstained with eosin only. Hematoxylin was not used because its blue color would have interfered with the interpretation of the trypan blue-staining.

Each glass slide was delineated into four quadrants and then viewed through a light microscope (Nikon Labophot-2) at high (x1,000) magnification with oil immersion. The assessing microscopist was unaware of the group identity for each slide. Twenty-five parenchymal cell nuclei were identified and counted in each of the four quadrants, and the color of each nucleus was recorded. A deliberate attempt was made to exclude white cells or macrophages from analysis. Cell nuclei were identified as either pink (viable) or blue (nonviable), the latter color imparted by the trypan blue, which stains the nuclei of nonviable cells. Each section was counted on a second occasion, and the average of the two counts was recorded for each histologic section. If the difference in the percentage of trypan blue–positive cells between counts was greater than 10%, a third assessment was done and the average determined. No attempt was made to establish whether cells were epithelial or endothelial.

Thus, the percentage of viable cells was determined for each animal in a blinded fashion. The percentage of viable cells in each rat lung specimen was used to calculate the mean percentage viability in each subgroup. By studying each of four quadrants of each histologic section, and by counting the same slide two or three times, possible variations in trypan blue staining resulting from nonhomogeneous dye distribution were minimized.

High-Performance Liquid Chromatography
One of three right lung portions was weighed (wet weight), stored in an oven at 80°C for 48 hours, and then reweighed (dry weight) using an analytical balance (Fischer Scientific, Pittsburgh, PA). The wet-to-dry weight ratio was calculated. The two remaining lung portions were used for adenosine triphosphate (ATP), adenosine diphosphate (ADP), or adenosine monophosphate (AMP) analysis.

The HPLC measurement of adenine nucleotides was performed as described previously [5]. The tissue samples for HPLC were pulverized using a liquid nitrogen–cooled Bessman pulverizer, and then homogenized in an ice-cooled test tube with ice-cooled 0.6-mol/L perchloric acid (5 mL/g tissue), using a tissue tearor (Biospec Products, Bartlesville, OK) set at high speed (30,000 rpm) for 30 seconds. After 2 minutes of centrifuging at 10,000 rpm, the supernatant was transferred into another ice-cooled test tube and buffered with 1-mol/L potassium phosphate dibasic (pH, 12) to achieve a pH of 6.8. The supernatant was separated from precipitated salt by repeat centrifuging for 2 minutes at 10,000 rpm. The remaining solution was passed through a 0.45-µm acro disc filter (Gelman Sciences, Ann Arbor, MI).

The ATP, ADP, and AMP concentrations were determined by HPLC using an LKB-Bromma apparatus (LKB-Produkter AB, Bromma, Sweden). To measure the ATP and ADP levels, a partisil 10 SAX Whatman column (Whatman, Inc, Clifton, NJ) in 0.25-mol/L potassium phosphate monobasic (pH, 6.5) was used at a flow rate of 1.5 mL/min. To measure the AMP level, an LC-18 Supelco column (Supelco, Inc, Bellafonte, PA) in 0.25-mol/L ammonium phosphate monobasic (pH, 4.5) was used at a flow rate of 2.0 mL/min. For each assessment, 50 µL of solution was injected into the HPLC system. Standard curves were constructed using serial dilutions (Sigma Chemical Co). An IBM 486 DX 33 MHz computer with Peaksimple II software (SRI Instruments, Torrance, CA) was used to record and process the data from the HPLC system.

Statistical Analysis
Differences between subgroups were analyzed statistically using analysis of variance. Data are presented as the mean ± standard errors of the mean. The differences were considered significant at a p value of less than 0.05. Total adenine nucleotide (TAN) levels were calculated according to the simple formula TAN = ATP + ADP + AMP, to document preservation of adenosine phosphate levels in lung tissue.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Histologic data are summarized in Figure 1Go. After 4 hours of 100% oxygen ventilation of circulation-arrested lungs plus 4 hours of hypothermic storage in EC, UW, or CR solutions, viability was found to vary between 72% ± 3% and 84% ± 2%. Within each group, the addition of PGE1 or PGE1 and DMTU had no significant effect on viability. However, the percentage of viable cells was always higher in the CR-flushed subgroups than it was in the UW- or EC-flushed subgroups. The differences between the CR and EC subgroups were statistically significant (p < 0.005). Discounting the addition of PGE1 or DMTU, lungs perfused with CR solution showed significantly higher viability than lungs flushed with EC or UW solution (p < 0.005). The cell viability observed in the EC and UW subgroups without additives was similar to that noted in the previous study [6].



View larger version (56K):
[in this window]
[in a new window]
 
Fig 1. . Percentage of viable cells (mean ± standard errors of the mean) in the three primary groups (Euro-Collins [EC], University of Wisconsin [UW], and Carolina rinse [CR]), each one divided into three subgroups. (p < 0.005 Euro-Collins subgroups versus similar Carolina rinse subgroups, by analysis of variance.) (DMTU = dimethylthiourea; PGE1 = prostaglandin E1.)

 
The lung adenine nucleotide levels are given in Table 2Go. The ATP levels were somewhat higher in lungs perfused with CR solution; this difference was statistically significant for lungs flushed with CR solution as compared with lungs flushed with EC solution. No statistically significant differences were observed among subgroups, however. The ATP levels for all subgroups are presented in Figure 2Go.


View this table:
[in this window]
[in a new window]
 
Table 2. . Metabolic Data on the Postmortem Rat Lunga
 


View larger version (48K):
[in this window]
[in a new window]
 
Fig 2. . Adenosine triphosphate (ATP) levels (mean ± standard errors of the mean) in the three primary groups (Euro-Collins [EC], University of Wisconsin [UW], and Carolina rinse [CR]), each one divided into three subgroups. Values are expressed as µmol/g dry weight. (DMTU = dimethylthiourea; PGE1 = prostaglandin E1.)

 
The TAN levels are shown in Figure 3Go. The TAN levels were favorably affected by the addition of PGE1 in each group. This was statistically significant for lungs flushed with EC solution. The addition of DMTU with PGE1 improved the TAN levels only in lungs flushed with EC or UW solution. Discounting the effects of the perfusate solution, lungs flushed with solutions containing PGE1 showed significantly higher TAN levels than those flushed with solutions not containing PGE1 (p < 0.05).



View larger version (48K):
[in this window]
[in a new window]
 
Fig 3. . Lung total adenine nucleotide (TAN) levels (mean ± standard errors of the mean) in the three primary groups (Euro-Collins [EC], University of Wisconsin [UW], and Carolina rinse [CR]), each one divided into three subgroups. Values are expressed as µmol/g dry weight. (DMTU = dimethylthiourea; PGE1 = prostaglandin E1.) (p < 0.005 EC type 1 subgroup versus EC type 2 and 3 subgroups; p < 0.0005 EC type 1 subgroup versus CR type 1 subgroup, by analysis of variance.)

 
The wet-to-dry weight ratios for each subgroup are shown in Figure 4Go. Lungs flushed with UW solution showed significantly lower wet-to-dry weight ratios than did lungs in the other groups (p < 0.0001). The addition of PGE1 to the CR solution appeared to have a modest benefit with respect to the wet-to-dry weight ratio. In our experience, a wet-to-dry weight ratio of normal rat lung freshly retrieved without flushing is 5.8 ± 0.5 (standard error). Thus flushing with UW solution resulted in normal wet-to-dry weight ratios, whereas flushing with EC or CR solution resulted in mild edema, as shown by elevation of this ratio.



View larger version (57K):
[in this window]
[in a new window]
 
Fig 4. . Wet-to-dry weight ratio (mean ± standard errors of the mean) in the three primary groups (Euro-Collins [EC], University of Wisconsin [UW], and Carolina rinse [CR]), each one divided into three subgroups. (p < 0.05 UW subgroups versus similar EC and CR subgroups, by analysis of variance.) (DMTU = dimethylthiourea; PGE1 = prostaglandin E1.)

 

    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Previous experiments in our laboratory, in which a rat model was used, have shown that 100% oxygen–ventilated lungs from non–heart beating donors retain parenchymal cell viability, ultrastructural integrity, and adenine nucleotide levels beyond 4 hours after death [35]. More recently we have demonstrated, using two different preservation solutions (EC and UW), that cadaveric rat lungs can withstand a supplemental period of cold storage after 4 hours of 100% oxygen ventilation. However, we noted a significant increase in the lung water content, as shown by the wet-to-dry weight ratios [6].

In a canine single-lung transplant model using cadaveric donors, we noted that the addition of DMTU to the EC flush solution lengthened the survival and lowered the increase in the amount of extravascular lung water during the 8-hour observation period [11]. In another experiment, we assessed parenchymal lung viability, using the trypan blue dye exclusion technique, in canine lungs ventilated for 2 hours with 100% oxygen after cardiocirculatory arrest and flushed with EC solution, with or without DMTU. The percentage of viable cells was slightly higher in the DMTU group (87% ± 5% versus 80% ± 7%). Also observed in this experiment was the finding that the amount of extravascular lung water at the end of the 8-hour observation period was lower in the DMTU group [12].

The current study was undertaken to ascertain whether the addition of PGE1 alone or with DMTU into two different preservation solutions (EC and UW) could improve the viability of or the adenine nucleotide levels in rat cadaveric lungs. Another aim of this study was to evaluate the CR solution as a pulmonary preservation solution.

A variety of studies have shown a beneficial effect from PGE1 in lung preservation using different types of solutions. Mulvin and associates [13] used Wallwork's solution for their experiment and concluded that the positive action of PGE1 correlated with the solution's vasodilative property rather than with other characteristics, such as antiplatelet aggregation, anti–white blood cell adherence, and cytoprotection. Patterson's group [14, 15] came to the same conclusion from two experiments in which PGE1 was used before lung perfusion with EC or low-potassium dextran solution. More recently, Lin and colleagues [16] utilized UW solution and concluded that the addition of PGE1 increased the safe lung preservation time.

The CR solution has been used successfully in experimental and clinical liver transplantation to rinse the grafts after the storage period and has been observed to decrease the amount of ischemic-reperfusion injury [9, 10]. Because this solution was designed as a "rinse solution," we evaluated its efficacy as a pulmonary rinse solution in a previous study [6]. In half of the experimental rat lungs, trypan blue was dissolved in this solution, whereas the other lungs were perfused with trypan blue dissolved in the usual Krebs-Ringers-HEPES buffer. In this model, CR solution was found to have no beneficial effect on viability. We reasoned that this failure may be due to the lack of time for this solution to effect recovery of the lungs. Because lungs in the current study were retrieved from non–heart beating donors and had already been subjected to a warm ischemic period, we decided to use CR solution as a preservation solution to flush and store cadaveric lungs. We chose to compare its effects with those of EC and UW solution under similar conditions.

In this study, viability was relatively well maintained in all subgroups. However, lungs flushed with CR solution fared better, and the percentage of viable cells was significantly higher in these subgroups. The highest percentage of viable parenchymal lung cells was seen for lungs flushed with CR solution with PGE1 and DMTU. Glycine, a component of the solution, has been shown to reduce ischemic-reperfusion injury and to improve function in and the survival of rat liver grafts after transplantation [17].

The TAN levels were consistently higher in lungs flushed with solutions containing PGE1. We speculate that this is due to a better distribution of perfusate, which provides a more uniform distribution of substrate for glycolysis. Although some investigators have evaluated the energy charge or ATP levels as end-points, we found in a prior study that the TAN levels correlated best with viability [5].

The addition of DMTU appeared to have little effect in this model. Because free radical–mediated processes generally require a period of reperfusion, it is possible that the potential benefit of a free radical scavenger could not be adequately assessed in this model. Because solutions containing DMTU and PGE1 together had effects similar to those found for solutions containing only PGE1, we decided not to pursue further studies in this model using DMTU alone.

Wet-to-dry weight ratios were better in lungs perfused with the UW solution. Perhaps this is related to the high-molecular-weight osmotic-impermeant components, which theoretically prevent cellular expansion during ischemia [18]. Hopkinson and colleagues [19] pointed out that the impermeant trisaccharide raffinose appears to be the major factor responsible for the efficacy of the UW solution in lung graft preservation.

In an earlier experiment [6], we employed a larger volume of flush solution (100 mL) and found substantial increases in the wet-to-dry weight ratios for cadaveric lungs. We chose to use a smaller volume of flush solution for the current experiments (50 mL), because this volume is more consistent with volumes used in clinical lung preservation for human transplantation. Even this volume, however, corresponds to a perfusion volume of 100 to 150 mL/kg, which should exaggerate any tendency for pulmonary edema to develop.

These studies lend support to the hypothesis that lungs retrieved from oxygen-ventilated cadavers may be suitable for transplantation. Further studies are necessary to elucidate the tolerable period of in situ ischemia and the tolerable period of hypothermic storage after retrieval from cadavers. The CR solution may be a useful pulmonary preservation strategy and merits further study. If lungs can maintain viability and provide good gas exchange function after retrieval from circulation-arrested cadavers, then the scarcity of suitable lung donors may be minimized.


    Acknowledgments
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Doctor D'Armini was funded by a grant from I.R.C.C.S. Policlinico San Matteo (Ric. Fin. Min. San. 070/RFM/93/01).

We express appreciation to David T. Currin and Kimberlie Burns for their excellent technical assistance; to DuPont Merck Pharmaceutical Company, Fresenius USA, Inc., and Upjohn Co for generous gifts of UW solution, EC solution, and PGE1, respectively; and to Betsy L. Mann for editorial assistance in the preparation of the manuscript.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Presented at the Poster Session of the Thirty-second Annual Meeting of The Society of Thoracic Surgeons, Orlando, FL, Jan 29–31, 1996.

Address reprint requests to Dr Egan, University of North Carolina at Chapel Hill, 108 Burnett-Womack Bldg, CB 7065, Chapel Hill, NC 27599-7065.


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Egan TM, Lambert CJ Jr, Reddick RL, Ulicny KS Jr, Keagy BA, Wilcox BR. A strategy to increase the donor pool: the use of cadaver lungs for transplantation. Ann Thorac Surg 1991;52:1113–21.[Abstract]
  2. Ulicny KS Jr, Egan TM, Lambert CJ Jr, Reddick RL, Wilcox BR. Cadaver lung donors: effect of preharvest ventilation on graft function. Ann Thorac Surg 1993;55:1185–91.[Abstract]
  3. D'Armini AM, Roberts CS, Griffith PK, Lemasters JJ, Egan TM. When does the lung die? I. Histochemical evidence of pulmonary viability after "death." J Heart Lung Transplant 1994;13:741–7.[Medline]
  4. Alessandrini F, D'Armini AM, Roberts CS, Reddick RL, Egan TM. When does the lung die? II. Ultrastructural evidence of pulmonary viability after "death." J Heart Lung Transplant 1994;13:748–57.[Medline]
  5. D'Armini AM, Tom EJ, Roberts CS, Henke DC, Lemasters JJ, Egan TM. When does the lung die? Time course of high energy phosphate depletion and relationship to lung viability after "death." J Surg Res 1995;59:468–74.[Medline]
  6. D'Armini AM, Egan TM, Roberts CS, Lemasters JJ. Lung retrieval from cadaver donors with nonbeating hearts: optimal preservation solution. J Heart Lung Transplant 1996;15:496–505.[Medline]
  7. Lambert CJ Jr, Egan TM, Keagy BA, Wilcox BR. Lung preservation with dimethylthiourea (DMTU). To flush or infuse? That is the question. Chest 1990;98(Suppl):11S.
  8. Lambert CJ Jr, Egan TM, Keagy BA, Detterbeck FC, Wilcox BR. Enhanced pulmonary function using dimethylthiourea for twelve-hour preservation. Ann Thorac Surg 1991;51:924–30.[Abstract]
  9. Gao W, Takei Y, Marzi I, et al. Carolina rinse solution-a new strategy to increase survival time after orthotopic liver transplantation in the rat. Transplantation 1991;52:417–24.[Medline]
  10. Sanchez-Urdazpal L, Gores GJ, Lemasters JJ, et al. Carolina rinse solution decreases liver injury during clinical liver transplantation. Transplant Proc 1993;25:1574–5.[Medline]
  11. Egan TM, Ulicny KS Jr, Lambert CJ Jr, Wilcox BR. Effect of a free radical scavenger on cadaveric lung transplantation. Ann Thorac Surg 1993;55:1453–9.[Abstract]
  12. Roberts CS, Hennington MH, D'Armini AM, Griffith PK, Lemasters JJ, Egan TM. Donor lungs from ventilated cadavers: impact of a free radical scavenger. J Heart Lung Transplant 1996;15:275–82.[Medline]
  13. Mulvin D, Jones K, Howard R, Grosso M, Repine J, Johnston M. The effect of prostacyclin as a constituent of a preservation solution in protecting lungs from ischemic injury because of its vasodilatatory properties. Transplantation 1990;49:828–30.[Medline]
  14. Mayer E, Puskas JD, Cardoso PFG, Shi S, Slutsky AS, Patterson GA. Reliable eighteen-hour lung preservation at 4° and 10°C by pulmonary artery flush after high-dose prostaglandin E1 administration. J Thorac Cardiovasc Surg 1992;103:1136–42.[Abstract]
  15. Puskas JD, Cardoso PFG, Mayer E, Slutsky AS, Patterson GA. Equivalent eighteen-hour lung preservation with low-potassium dextran or Euro-Collins solution after prostaglandin E1 infusion. J Thorac Cardiovasc Surg 1992;104:83–9.[Abstract]
  16. Lin PJ, Hsieh M-J, Cheng K-S, Kuo T-T, Chang C-H. University of Wisconsin solution extends lung preservation after prostaglandin E1 infusion. Chest 1994;105:255–61.[Abstract/Free Full Text]
  17. Bachmann S, Peng XX, Currin RT, Thurman RG, Lemasters JJ. Glycine in Carolina rinse solution reduces reperfusion injury, improves graft function, and increases graft survival after rat liver transplantation. Transplant Proc 1995;27:741–2.[Medline]
  18. Hopkinson DN, Odom NJ, Bridgewater BJM, Hooper TL. Lung graft preservation: comparison of phosphate-buffered sucrose, modified Euro Collins, and University of Wisconsin solutions. Transplantation 1994;58:763–8.[Medline]
  19. Hopkinson DN, Odom NJ, Bridgewater BJM, Hooper TL. University of Wisconsin solution for lung graft preservation: which components are important? J Heart Lung Transplant 1994;13:990–7.[Medline]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
S. FISCHER, A. A. MACLEAN, M. LIU, J. A. CARDELLA, A. S. SLUTSKY, M. SUGA, J. F. M. MOREIRA, and S. KESHAVJEE
Dynamic Changes in Apoptotic and Necrotic Cell Death Correlate with Severity of Ischemia-Reperfusion Injury in Lung Transplantation
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1932 - 1939.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. S. Bleiweis, D. R. Jones, S. C. Hoffmann, R. M. Becker, and T. M. Egan
Reduced ischemia-reperfusion injury with rolipram in rat cadaver lung donors: effect of cyclic adenosine monophosphate
Ann. Thorac. Surg., January 1, 1999; 67(1): 194 - 199.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. E. M. Van Raemdonck, N. C. P. Jannis, F. R. L. Rega, P. R. J. De Leyn, W. J. Flameng, and T. E. Lerut
Extended Preservation of Ischemic Pulmonary Graft by Postmortem Alveolar Expansion
Ann. Thorac. Surg., September 1, 1997; 64(3): 801 - 808.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrea M. D'Armini
Thomas M. Egan
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Armini, A. M.
Right arrow Articles by Egan, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Armini, A. M.
Right arrow Articles by Egan, T. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS